Treatment with Mesenchymal Stem Cells Improves Renovascular Hypertension and Preserves the Ability of the Contralateral Kidney to Excrete Sodium

• Main Authors: Vanessa Araujo Varela (Author), Elizabeth B. Oliveira-Sales (Author), Edgar Maquigussa (Author), Fernanda T. Borges (Author), Pedro P. Gattai (Author), Antonio da S. Novaes (Author), Caroline G. Shimoura (Author), Ruy R. Campos (Author), Mirian A. Boim (Author)
• Format: Book
• Published: Karger Publishers, 2019-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Mesenchymal stem cells (MSC) improve renal function and renovascular hypertension in the 2-kidney 1-clip model (2K-1C). While MSC play an immunomodulatory role, induce neoangiogenesis, and reduce fibrosis, they do not correct sodium loss by the contra­lateral kidney. Objectives: We inves...